{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:04:51Z","timestamp":1786115091469,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["BE2018689"],"award-info":[{"award-number":["BE2018689"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072754"],"award-info":[{"award-number":["82072754"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["M2020011"],"award-info":[{"award-number":["M2020011"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.hbpd.2026.04.002","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:34:00Z","timestamp":1775842440000},"page":"432-445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exosomal hnRNPA2B1 suppresses irinotecan-induced ferroptosis in pancreatic cancer"],"prefix":"10.1016","volume":"25","author":[{"given":"Xu-Lin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Chun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Min","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Wei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2026.04.002_bib0001","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0002","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0003","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231175441","article-title":"Real-world dose reduction of standard and modified FOLFIRINOX in metastatic pancreatic cancer: a systematic review, evidence-mapping, and meta-analysis","volume":"15","author":"Jung","year":"2023","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104398","article-title":"Irinotecan: 25 years of cancer treatment","volume":"148","author":"Bailly","year":"2019","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10787-022-01115-7","article-title":"Exosome engineering in cell therapy and drug delivery","volume":"31","author":"Sadeghi","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0006","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.2147\/IJN.S264498","article-title":"Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications","volume":"15","author":"Zhang","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0007","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12032-023-02101-x","article-title":"Impact of exosome therapy on pancreatic cancer and its progression","volume":"40","author":"El-Tanani","year":"2023","journal-title":"Med Oncol"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0008","doi-asserted-by":"crossref","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0009","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1186\/s12885-023-11239-w","article-title":"Exosomal ACADM sensitizes gemcitabine-resistance through modulating fatty acid metabolism and ferroptosis in pancreatic cancer","volume":"23","author":"Yang","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11010-019-03545-4","article-title":"Exosomes: cell-created drug delivery systems","volume":"459","author":"Familtseva","year":"2019","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0011","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0012","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41416-022-01998-x","article-title":"Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy","volume":"128","author":"Ajoolabady","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110262","article-title":"Trabectedin induces ferroptosis via regulation of HIF-1\u03b1\/IRP1\/TFR1 and Keap1\/Nrf2\/GPX4 axis in non-small cell lung cancer cells","volume":"369","author":"Cai","year":"2023","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0014","article-title":"Ferroptosis: at the crossroad of gemcitabine resistance and tumorigenesis in pancreatic cancer","volume":"22","author":"Yang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0015","doi-asserted-by":"crossref","first-page":"e1612","DOI":"10.1002\/wrna.1612","article-title":"The roles of hnRNP A2\/B1 in RNA biology and disease","volume":"12","author":"Liu","year":"2021","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0016","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10142-023-01279-7","article-title":"HNRNPA2B1-mediated m6A modification of FOXM1 promotes drug resistance and inhibits ferroptosis in endometrial cancer via regulation of LCN2","volume":"24","author":"Jiang","year":"2023","journal-title":"Funct Integr Genomics"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0017","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12943-023-01824-9","article-title":"Extracellular vesicle-circEHD2 promotes the progression of renal cell carcinoma by activating cancer-associated fibroblasts","volume":"22","author":"He","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0018","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12943-019-0982-6","article-title":"Exosome-orchestrated hypoxic tumor microenvironment","volume":"18","author":"Meng","year":"2019","journal-title":"Mol Cancer"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0019","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13048-025-01718-y","article-title":"hnRNPA2B1 restrains granulosa cell ferroptosis by m6A\/SLC7A11 in premature ovarian failure","volume":"18","author":"Xiong","year":"2025","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1372330","article-title":"Regulation of ferroptosis by PI3K\/Akt signaling pathway: a promising therapeutic axis in cancer","volume":"12","author":"Su","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0021","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12957-021-02291-6","article-title":"The role of FOLFIRINOX in metastatic pancreatic cancer: a meta-analysis","volume":"19","author":"Zhang","year":"2021","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0022","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1111\/cas.15377","article-title":"Liposomal irinotecan (Onivyde): exemplifying the benefits of nanotherapeutic drugs","volume":"113","author":"Milano","year":"2022","journal-title":"Cancer Sci"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0023","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.3390\/cells12202509","article-title":"SLC38A5 Modulates ferroptosis to overcome gemcitabine resistance in pancreatic cancer","volume":"12","author":"Kim","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0024","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12943-019-0991-5","article-title":"Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance","volume":"18","author":"Mashouri","year":"2019","journal-title":"Mol Cancer"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0025","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1007\/s11033-021-07007-3","article-title":"Gastrointestinal cancer drug resistance: the role of exosomal miRNAs","volume":"49","author":"Salehi","year":"2022","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0026","doi-asserted-by":"crossref","DOI":"10.1126\/science.aav0758","article-title":"Nuclear hnRNPA2B1 initiates and amplifies the innate immune response to DNA viruses","volume":"365","author":"Wang","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0027","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/CIRCULATIONAHA.122.059591","article-title":"HNRNPA2B1: RNA-binding protein that orchestrates smooth muscle cell phenotype in pulmonary arterial hypertension","volume":"146","author":"Ruffenach","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0028","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.molcel.2023.01.003","article-title":"SUMOylation of HNRNPA2B1 modulates RPA dynamics during unperturbed replication and genotoxic stress responses","volume":"83","author":"Zhu","year":"2023","journal-title":"Mol Cell"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.666451","article-title":"hnRNPA2B1 promotes colon cancer progression via the MAPK pathway","volume":"12","author":"Tang","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0030","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12935-021-01968-y","article-title":"hnRNPA2B1 regulates the alternative splicing of BIRC5 to promote gastric cancer progression","volume":"21","author":"Peng","year":"2021","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0031","article-title":"HNRNPA2B1 demonstrates diagnostic and prognostic values based on pan-cancer analyses","volume":"2022","author":"Chen","year":"2022","journal-title":"Comput Math Methods Med"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0032","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12967-023-04190-8","article-title":"HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p\/PTEN axis","volume":"21","author":"Li","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.hbpd.2026.04.002_bib0033","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/s41374-020-0466-8","article-title":"The HNRNPA2B1-MST1R-Akt axis contributes to epithelial-to-mesenchymal transition in head and neck cancer","volume":"100","author":"Gupta","year":"2020","journal-title":"Lab Invest"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387226000482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387226000482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:02:40Z","timestamp":1785974560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387226000482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1499387226000482"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2026.04.002","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exosomal hnRNPA2B1 suppresses irinotecan-induced ferroptosis in pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2026.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}